In Women with Prior Gestational Diabetes Mellitus, the Glucagon-Like-Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-Out

Emilie S. Andersen; Signe Foghsgaard; Louise Vedtofte; Marie H. Pedersen; Julie Forman; Elisabeth R. Mathiesen; Jens Svare; Jens J. Holst; Tine D. Clausen; Peter Damm; Filip K. Knop; Tina Vilsboll

doi:10.2337/db21-10-OR

In Women with Prior Gestational Diabetes Mellitus, the Glucagon-Like-Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-Out

Emilie S. Andersen, Signe Foghsgaard, Louise Vedtofte, Marie H. Pedersen, Julie Forman, Elisabeth R. Mathiesen, Jens Svare, Jens J. Holst, Tine D. Clausen, Peter Damm, Filip K. Knop, Tina Vilsboll

Originalsprog	Engelsk
Publikationsdato	jun. 2021
DOI	https://doi.org/10.2337/db21-10-OR
Status	Udgivet - jun. 2021

Adgang til dokumentet

10.2337/db21-10-OR

Citationsformater

Andersen, E. S., Foghsgaard, S., Vedtofte, L., Pedersen, M. H., Forman, J., Mathiesen, E. R., Svare, J., Holst, J. J., Clausen, T. D., Damm, P., Knop, F. K., & Vilsboll, T. (2021). In Women with Prior Gestational Diabetes Mellitus, the Glucagon-Like-Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-Out. https://doi.org/10.2337/db21-10-OR

In Women with Prior Gestational Diabetes Mellitus, the Glucagon-Like-Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-Out. / Andersen, Emilie S.; Foghsgaard, Signe ; Vedtofte, Louise et al.

2021.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

Andersen, ES , Foghsgaard, S , Vedtofte, L, Pedersen, MH, Forman, J, Mathiesen, ER , Svare, J, Holst, JJ, Clausen, TD, Damm, P , Knop, FK & Vilsboll, T 2021, 'In Women with Prior Gestational Diabetes Mellitus, the Glucagon-Like-Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-Out'. https://doi.org/10.2337/db21-10-OR

@conference{3e23a07a367845eca1265a8b962032de,

title = "In Women with Prior Gestational Diabetes Mellitus, the Glucagon-Like-Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-Out",

author = "Andersen, {Emilie S.} and Signe Foghsgaard and Louise Vedtofte and Pedersen, {Marie H.} and Julie Forman and Mathiesen, {Elisabeth R.} and Jens Svare and Holst, {Jens J.} and Clausen, {Tine D.} and Peter Damm and Knop, {Filip K.} and Tina Vilsboll",

year = "2021",

month = jun,

doi = "10.2337/db21-10-OR",

language = "English",

}

TY - ABST

T1 - In Women with Prior Gestational Diabetes Mellitus, the Glucagon-Like-Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-Out

AU - Andersen, Emilie S.

AU - Foghsgaard, Signe

AU - Vedtofte, Louise

AU - Pedersen, Marie H.

AU - Forman, Julie

AU - Mathiesen, Elisabeth R.

AU - Svare, Jens

AU - Holst, Jens J.

AU - Clausen, Tine D.

AU - Damm, Peter

AU - Knop, Filip K.

AU - Vilsboll, Tina

PY - 2021/6

Y1 - 2021/6

U2 - 10.2337/db21-10-OR

DO - 10.2337/db21-10-OR

M3 - Conference abstract for conference

ER -